Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis

OBJECTIVES: To study the efficacy and safety of Withania somnifera (WS, Ashwagandha) in the prophylaxis against COVID-19 in high risk health care workers (HCW) in comparison to hydroxychloroquine (HCQ). To evaluate the general physical and mental health benefits of Ashwagandha. METHODS: A 16 week ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Chopra, Arvind, Srikanth, Narayanam, Patwardhan, Bhushan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372474/
https://www.ncbi.nlm.nih.gov/pubmed/34418550
http://dx.doi.org/10.1016/j.ctim.2021.102768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372474/
https://www.ncbi.nlm.nih.gov/pubmed/34418550
http://dx.doi.org/10.1016/j.ctim.2021.102768

Ejemplares similares